This content is unpublished, click the edit tab and check "Published" on the bottom of the form.
11.
06.15
08:01
Close share menu
Bristol-Myers Squibb demonstrates commitment to hematology and advancing research and development across multiple blood cancers through immuno-Oncology leadership at the 20th Congress of the European Hematology Association